MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fmolb.2025.1710650

Медицинская библиотека · Frontiers in molecular biosciences · 2026

Pyrrolopyrimidine derivatives as dual COX-2/ACE2 inhibitors: design, synthesis, and anti-inflammatory evaluation.

Afifi Hala, Fatahala Samar S, Abd El-Hameed Rania H, Mahgoub Shahenda, El-Haggar Radwan, Aly Omnia, Gharib Amal F, Sayed Amira I, Taha Heba

СтатьяПеревод пока не подготовлен

Аннотация

In this study, we report the design and synthesis of a new series of pyrrolopyrimidine derivatives developed as dual-target nonsteroidal anti-inflammatory agents (NSAIDs). The compounds were evaluated for anti-inflammatory properties, cyclooxygenase-1/2 (COX-1/COX-2) inhibitory activity, and angiotensin-converting enzyme 2 (ACE2)-blocking activity in lipopolysaccharide (lipopolysaccharide)-stimulated RAW264.7 cells. Among the synthesized molecules, compounds 5a and 5b showed potent dual inhibitory activity, which was supported by molecular docking and molecular dynamics simulations. These findings highlight the potential of selective COX-2 inhibitors with concurrent ACE2 blockade as a promising therapeutic approach for controlling inflammation and modulating pathways relevant to viral entry and other inflammation-associated disorders. While ACE2 inhibition has received particular attention in the context of recent viral infections, the broader anti-inflammatory efficacy of these derivatives supports their potential as multi-target drug candidates.

Для цитирования: Afifi Hala, Fatahala Samar S, Abd El-Hameed Rania H, Mahgoub Shahenda, El-Haggar Radwan, Aly Omnia, Gharib Amal F, Sayed Amira I, Taha Heba. Pyrrolopyrimidine derivatives as dual COX-2/ACE2 inhibitors: design, synthesis, and anti-inflammatory evaluation.. Frontiers in molecular biosciences. 2026. DOI: 10.3389/fmolb.2025.1710650.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.